- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1262
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Review of local injection of anti-TNF for perianal fistulising Crohn’s disease ; volume:32 ; number:11 ; day:12 ; month:9 ; year:2017 ; pages:1539-1544 ; date:11.2017
International journal of colorectal disease ; 32, Heft 11 (12.9.2017), 1539-1544, 11.2017
- Creator
-
Adegbola, Samuel O.
- Contributor
-
Sahnan, Kapil
Tozer, Philip J.
Phillips, Robin KS
Faiz, Omar D.
Warusavitarne, Janindra
Hart, Ailsa
SpringerLink (Online service)
- DOI
-
10.1007/s00384-017-2899-0
- URN
-
urn:nbn:de:1111-201711155637
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adegbola, Samuel O.
- Sahnan, Kapil
- Tozer, Philip J.
- Phillips, Robin KS
- Faiz, Omar D.
- Warusavitarne, Janindra
- Hart, Ailsa
- SpringerLink (Online service)
Other Objects (12)
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
Insights into treatment of complex Crohn's perianal fistulas
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
Insights into treatment of complex Crohn's perianal fistulas
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients